Company profile: Shape Memory Medical
1.1 - Company Overview
Company description
- Provider of shape memory polymer–based medical devices for embolization, including IMPEDE Embolization Plug for space filling and occlusion, IMPEDE-FX Embolization Plug for optimized stasis and stable clot formation, IMPEDE-FX RapidFill to quickly occlude large vessels or spaces, and TrelliX Embolic Coil for neurovascular and peripheral use; plus the AAA-SHAPE clinical trial evaluating IMPEDE-FX devices for AAA sac filling outside of an EVAR stent graft.
Products and services
- IMPEDE-FX Embolization Plug: A biocompatible smart-polymer plug engineered to optimize stasis and form stable clots, augmenting IMPEDE for additional space filling in embolization procedures
- IMPEDE-FX RapidFill: A high-capacity delivery product that dispenses 6.25 mL of smart polymer in one application to quickly fill and occlude large vessels or spaces, enabling space and track filling
- IMPEDE Embolization Plug: A shape-memory polymer-based component constructed to obstruct or reduce blood flow in peripheral vasculature by effectively filling space and achieving durable occlusion
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Shape Memory Medical
Axovan
HQ: Switzerland
Website
- Description: Provider of drug development specializing in G protein-coupled receptors, based in Switzerland.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Axovan company profile →
LipoScience
HQ: United States
Website
- Description: Provider of personalized diagnostics based on nuclear magnetic resonance (NMR) technology. Its first proprietary diagnostic test, the NMR LipoProfile® test, measures the number of low density lipoprotein particles (LDL-P) in a blood sample and provides physicians and their patients with actionable information.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full LipoScience company profile →
Exithera Pharmaceuticals
HQ: United States
Website
- Description: Provider of antithrombotic and stroke prevention drug development, offering novel, potent, selective small-molecule Factor XIa inhibitors, including frunexian to prevent thrombosis without increased bleeding risk, and EP-7041 evaluated in a Phase 2 trial to prevent thrombosis in COVID-19 ICU patients and investigated to inhibit ECMO-related thrombosis while minimizing bleeding risk.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Exithera Pharmaceuticals company profile →
Ash Access Technology
HQ: United States
Website
- Description: Provider of technologies and devices to treat and prevent the clinical consequences of vascular access-related diseases, including central line hemodialysis catheters designed to prevent fibrous sheaths, split-tip dialysis catheters, 7% sodium citrate catheter lock solutions, an extracorporeal charcoal-based sorbent liver dialysis system, and skin prep for vascular access procedures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ash Access Technology company profile →
Morphogen-IX
HQ: United Kingdom
Website
- Description: Provider of drug discovery developing bone morphogenetic proteins as a novel therapy for pulmonary arterial hypertension, a severe, life-limiting disease affecting lung blood vessels and leading to heart failure; founded in 2015 by Index Ventures.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Morphogen-IX company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Shape Memory Medical
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Shape Memory Medical
2.2 - Growth funds investing in similar companies to Shape Memory Medical
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Shape Memory Medical
4.2 - Public trading comparable groups for Shape Memory Medical
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →